TNF and influenza: As different influenza vaccine strategies are pursued, including adjuvanted vaccines [61] and a pan-influenza vaccine [62], [63], it may be important to maintain a balance between effectors and the IFNγ−IL-2+TNFα+ producing cells, similar to that observed with tetanus toxoid and other protective protein vaccines [5].